DAFNA Capital Management »

Cybin shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Cybin (HELP) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Cybin

Tip: Access up to 7 years of quarterly data

All positions including Cybin held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.7M 455k 8.18

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Stereotaxis Com New (STXS)
AtriCure (ATRC)
Cytokinetics Com New (CYTK)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Xenon Pharmaceuticals (XENE)
Ishares Nasdaq Biotech Indx Etf (IBB)
Biohaven (BHVN)
Arcus Biosciences Incorporated (RCUS)
Neurocrine Biosciences (NBIX)
Day One Biopharmaceuticals I (DAWN)
Tandem Diabetes Care Com New (TNDM)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for DAFNA Capital Management

Top funds holding Cybin

Point72 Asset Management
VR Adviser
Rosalind Advisors
Eventide Asset Management
Deep Track Capital
Sphera Funds Management
DCF Advisers
Acorn Capital Advisors
Susquehanna International
Nan Fung Group Holdings
DAFNA Capital Management
Stonepine Capital Management
Knott David M Jr
DLD Asset Management
ADAR1 Capital Management

View all funds holding Cybin